Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1595

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP01 - Early Stage/Localized Disease

    • Type: Posters (Featured)
    • Track: Early Stage/Localized Disease
    • +

      FP01.01 - Uniportal Versus Multiportal Video-Assisted Thoracoscopic Surgery for Non-Small Cell Lung Cancer: An Updated Meta-Analysis  

      00:00 - 00:00  |  Presenting Author(s): Maria P. Fergadi

      • Abstract

      Loading...

    • +

      FP01.02 - The Efficacy of Postoperative Radiotherapy in IIIA-N2 Non-Squamous NSCLC with Different EGFR Mutation Status: A Retrospective Analysis

      00:00 - 00:00  |  Presenting Author(s): Fang Wu

      • Abstract

      Loading...

    • +

      FP01.03 - Genetic Predisposition for Pre-Invasive Lung Adenocarcinoma Manifesting as Ground-Glass Nodules with Family History of Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Rui Fu

      • Abstract

      Loading...

    • +

      FP01.04 - BTCRC LUN19-396:  Adjuvant Chemotherapy Plus Atezolizumab in Stage IB-IIIA Resected NSCLC and Clearance of ctDNA

      00:00 - 00:00  |  Presenting Author(s): Melissa Yan

      • Abstract

      Loading...

    • +

      FP01.05 - The ASCENT Trial: A Phase II Study of Neoadjuvant/Adjuvant Afatinib, Chemoradiation +/- Surgery for Stage III EGFR-Mutant NSCLC

      00:00 - 00:00  |  Presenting Author(s): Andrew Piper-Vallillo

      • Abstract

      Loading...

  • +

    FP02 - Health Services Research/Health Economics

    • Type: Posters (Featured)
    • Track: Health Services Research/Health Economics
    • +

      FP02.01 - Patient Responses to Passive Enrollment into a Large, Pragmatic Clinical Trial: A Qualitative Content Analysis

      00:00 - 00:00  |  Presenting Author(s): Emily Jane Rozema

      • Abstract

      Loading...

    • +

      FP02.02 - Real-World Outcomes Among Advanced Non-Small Cell Lung Cancer Patients Re-Treated with Immunotherapy in the US

      00:00 - 00:00  |  Presenting Author(s): Alex I. Spira

      • Abstract

      Loading...

    • +

      FP02.03 - Changing Survival and Treatment Patterns in Patients Aged 80 or Older with Stage IV Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Matthew Anaka

      • Abstract

      Loading...

    • +

      FP02.04 - NSCLC with TPS>90% could have Higher Possibility of Causing Severe irAE; Retrospective Investigation in one Institution

      00:00 - 00:00  |  Presenting Author(s): Yuki Akazawa

      • Abstract

      Loading...

    • +

      FP02.05 - Value-Based Healthcare Study (VBHC) for Treating Lung Cancer in Victoria, Australia

      00:00 - 00:00  |  Presenting Author(s): Susan Harden

      • Abstract

      Loading...

    • +

      FP02.06 - Implementation of a Lung Cancer Value-Based Care Framework in a Low and Middle-Income Country Institution

      00:00 - 00:00  |  Presenting Author(s): Clarissa Baldotto

      • Abstract

      Loading...

    • +

      FP02.07 - Predicting the Future: Using AI to Predict Treatment Outcomes in Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Lawek Berzenji

      • Abstract

      Loading...

    • +

      FP02.08 - Importance of Stakeholder Engagement in a Patient-Centered Outcomes Research Trial

      00:00 - 00:00  |  Presenting Author(s): Visanee Vicky Musigdilok

      • Abstract

      Loading...

    • +

      FP02.09 - Effects of Chinese Reimbursement Policy on Molecular Diagnosis and Therapy of NSCLC from the Northern Part of Henan Province

      00:00 - 00:00  |  Presenting Author(s): Min Zhang

      • Abstract

      Loading...

    • +

      FP02.10 - Predictors of Moderate-to-Severe Symptoms in Stage IV NSCLC: A Population-Based Study of Patient Reported Outcomes

      00:00 - 00:00  |  Presenting Author(s): Michael C Tjong

      • Abstract

      Loading...

  • +

    FP03 - Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)

    • Type: Posters (Featured)
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      FP03.01 - Immune Microenvironment Features and Efficacy of PD-1/PD-L1 Blockade in Non-Small-Cell Lung Cancer Patients with EGFR or HER2 Exon 20 Insertions

      00:00 - 00:00  |  Presenting Author(s): Yun Fan

      • Abstract

      Loading...

    • +

      FP03.02 - Interim Analysis of Neoadjuvant Chemoradiotherapy and Durvalumab for Potentially Resectable Stage III Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Min Hee Hong

      • Abstract

      Loading...

    • +

      FP03.03 - Clinical Activity of BMS-986012, an Anti–Fucosyl-GM1 Monoclonal Antibody, Plus Nivolumab in Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Neal E. Ready

      • Abstract

      Loading...

    • +

      FP03.04 - Selinexor can Inhibit Nuclear Export of HMGB1, a Negative Predictive Marker for Immunotherapy Response

      00:00 - 00:00  |  Presenting Author(s): Jillian W.P. Bracht

      • Abstract

      Loading...

    • +

      FP03.05 - TLR9 Agonist CMP-001 Plus Atezolizumab +/- Radiation Therapy in Patients With PD-1 Blockade Resistant Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Marcelo V. Negrao

      • Abstract

      Loading...

  • +

    FP04 - Locoregional and Oligometastatic Disease

    • Type: Posters (Featured)
    • Track: Locoregional and Oligometastatic Disease
    • +

      FP04.01 - Heart Dose is a Dosimetric Predictor of Overall Survival in Patients with NSCLC Undergoing Post-Operative Radiation Therapy

      00:00 - 00:00  |  Presenting Author(s): Annemarie Fernandes Shepherd

      • Abstract

      Loading...

    • +

      FP04.02 - Feasibility of Radiotherapy Planning in the First 50 Patients Recruited to the ADSCaN Clinical Trial

      00:00 - 00:00  |  Presenting Author(s): Romaana Mir

      • Abstract

      Loading...

    • +

      FP04.03 - Dynamic Liquid Biopsy for Selecting Advanced NSCLC Patients for Primary Tumor Resection After Targeted Therapy

      00:00 - 00:00  |  Presenting Author(s): Weitao Zhuang

      • Abstract

      Loading...

    • +

      FP04.04 - EGFR Mutations Predict Superior Survival of NSCLC Patients with Oligometastatic Disease Treated with Local Consolidative Therapy

      00:00 - 00:00  |  Presenting Author(s): Ahsan Farooqi

      • Abstract

      Loading...

    • +

      FP04.05 - Anti-Vascular Drug Anlotinib Combined With SRS Versus SRS Alone for Brain Metastases From NSCLC: A Case Control Study

      00:00 - 00:00  |  Presenting Author(s): Hongqing Zhuang

      • Abstract

      Loading...

  • +

    FP05 - Mesothelioma, Thymoma and Other Thoracic Malignancies

    • Type: Posters (Featured)
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      FP05.01 - Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Choice of Second-line Therapy  

      00:00 - 00:00  |  Presenting Author(s): Kathleen Claire Kerrigan

      • Abstract

      Loading...

    • +

      FP05.02 - An Early Detection and Prognostic Blood Biomarkers Signature for Malignant Pleural Mesothelioma Based on Targeted Proteomics

      00:00 - 00:00  |  Presenting Author(s): Ferdinando Cerciello

      • Abstract

      Loading...

    • +

      FP05.03 - Association between Baseline Tumor Thickness and Response to Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Nicolas Zhou

      • Abstract

      Loading...

    • +

      FP05.04 - Outcomes of Resected Thymic Epithelial Tumors (TET), insights from RYTHMIC

      00:00 - 00:00  |  Presenting Author(s): Jose Carlos Benitez

      • Abstract

      Loading...

  • +

    FP06 - Palliative and Supportive Care

    • Type: Posters (Featured)
    • Track: Palliative and Supportive Care
    • +

      FP06.01 - Discrete Choice Experiment to Estimate Physicians’ Preferences in Terms of G-CSF use for Febrile Neutropenia Primary and Secondary Prophylaxis

      00:00 - 00:00  |  Presenting Author(s): Christos Chouaïd

      • Abstract

      Loading...

    • +

      FP06.02 - Treatment Decision-Making and Decisional Support Experiences Among Lung Cancer Patients and Survivors

      00:00 - 00:00  |  Presenting Author(s): Kelly Clark

      • Abstract

      Loading...

    • +

      FP06.03 - Treatment Past Progression with Second Line Nivolumab in Advanced Stage NSCLC

      00:00 - 00:00  |  Presenting Author(s): Zamzam Salam Al-Hashami

      • Abstract

      Loading...

    • +

      FP06.04 - Psychological Distress in Outpatients with Lymphoma, Lung and Breast Cancer During COVID-19 Pandemic

      00:00 - 00:00  |  Presenting Author(s): Domenico Galetta

      • Abstract

      Loading...

  • +

    FP07 - Pathology

    • Type: Posters (Featured)
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      FP07.01 - Dysbiosis of Gut Microbiota Suppress the Brain Metastasis of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Xiaorong Dong

      • Abstract

      Loading...

    • +

      FP07.02 - Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC

      00:00 - 00:00  |  Presenting Author(s): Alexander Haragan

      • Abstract

      Loading...

    • +

      FP07.03 - Landscape Heterogeneity of PD-L1 Expression and Immune Cells Predicts Prognosis of Metastatic Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Dong-Mei Lin

      • Abstract

      Loading...

    • +

      FP07.04 - Predictive Efficacy of Morphological Biomarkers Based on Digital Pathology for ICI Therapy of Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Noriko Motoi

      • Abstract

      Loading...

    • +

      FP07.05 - An Optimized Neoantigen Load Model Based on Immune Editing to Predict Response and Prognosis of Immune Checkpoint Therapy

      00:00 - 00:00  |  Presenting Author(s): Haoxuan Jin

      • Abstract

      Loading...

    • +

      FP07.06 - Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.

      00:00 - 00:00  |  Presenting Author(s): Laura Mezquita

      • Abstract

      Loading...

    • +

      FP07.07 - Value of the Lung Immune Prognostic Index (LIPI) As a Prognostic Tool for Real-World Patients Treated for Mutation-Positive Metastatic NSCLC

      00:00 - 00:00  |  Presenting Author(s): Amanda Jane Williams Gibson

      • Abstract

      Loading...

    • +

      FP07.08 - A Pan-Canadian Validation Study for the Detection of EGFR-T790M Mutations Using Circulating Tumour DNA (ctDNA) from Blood

      00:00 - 00:00  |  Presenting Author(s): Shamini Selvarajah

      • Abstract

      Loading...

    • +

      FP07.09 - Detection of Early Lung Cancer from Average-Risk Individuals and from Benign Nodule Carriers with a DNA Methylation Blood Test

      00:00 - 00:00  |  Presenting Author(s): Baohui Han

      • Abstract

      Loading...

    • +

      FP07.10 - Circulating Tumor DNA Analysis in NSCLC with MET exon 14 Skipping Alterations

      00:00 - 00:00  |  Presenting Author(s): Xiuning Le

      • Abstract

      Loading...

    • +

      FP07.11 - Circulating Tumor DNA (ctDNA) Clearance as a Biomarker in Patients With Locally Advanced NSCLC Following Chemoradiation

      00:00 - 00:00  |  Presenting Author(s): Brendan James Knapp

      • Abstract

      Loading...

    • +

      FP07.12 - Underdiagnosis of EGFR Exon 20 Insertion Mutation Variants: Estimates from NGS-based Real-World Datasets

      00:00 - 00:00  |  Presenting Author(s): Joshua M. Bauml

      • Abstract

      Loading...

    • +

      FP07.13 - Clinical Characteristics and Outcomes in Patients With KRAS G12C Mutated Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Bruna Pellini

      • Abstract

      Loading...

    • +

      FP07.14 - Implementation of a Lung Biopsy Histology Protocol Supports Successful Cancer Biomarker Testing

      00:00 - 00:00  |  Presenting Author(s): Sarah Wu

      • Abstract

      Loading...

    • +

      FP07.15 - Real-world ALK Testing Trends and Patterns in Patients with Advanced NSCLC in the United States

      00:00 - 00:00  |  Presenting Author(s): Christine M. Lovly

      • Abstract

      Loading...

    • +

      FP07.16 - Trends in Biomarker Testing Among Advanced NSCLC Patients in Oncology Practice Settings in the US

      00:00 - 00:00  |  Presenting Author(s): Lauren Bartolome

      • Abstract

      Loading...

    • +

      FP07.17 - The Impact of Blood Based Host Immune Profile to Identify Aggressive Early Stage NSCLC  

      00:00 - 00:00  |  Presenting Author(s): Eric Schaefer

      • Abstract

      Loading...

  • +

    FP09 - Screening and Early Detection

    • Type: Posters (Featured)
    • Track: Screening and Early Detection
    • +

      FP09.01 - Economic Impact of Screening Selection with the PLCOm2012 Risk Model Versus USPSTF-Guidelines in the International Lung Screening Trial (ILST) 

      00:00 - 00:00  |  Presenting Author(s): Sonya Cressman

      • Abstract

      Loading...

    • +

      FP09.02 - Calibration of the LLP Lung Cancer Risk Stratification Model: Prospective Validation in the UKLS Cohort of 76,000 People

      00:00 - 00:00  |  Presenting Author(s): John K Field

      • Abstract

      Loading...

    • +

      FP09.03 - Circulating Nucleosomes in Lung Cancer Diagnosis Following Low-Dose Computed Tomography

      00:00 - 00:00  |  Presenting Author(s): Tung Ming Tsai

      • Abstract

      Loading...

    • +

      FP09.04 - Association Between Family History and Other Risk Factors for Lung Cancer: Analysis of an Internet-Based Risk Assessment

      00:00 - 00:00  |  Presenting Author(s): Ryan O'Keefe

      • Abstract

      Loading...

    • +

      FP09.05 - Driver Oncogenic Alterations and Indoor Radon in NSCLC Patients From the IFCT Biomarker Cohort: Bioradon France Study

      00:00 - 00:00

      • Abstract

      Loading...

  • +

    FP10 - Small Cell Lung Cancer/NET

    • Type: Posters (Featured)
    • Track: Small Cell Lung Cancer/NET
    • +

      FP10.01 - Survival in Advanced SCLC: Projected Impact of Immuno-Oncology-Associated Durable Response on Population Health Gains in US

      00:00 - 00:00  |  Presenting Author(s): Jason Gordon

      • Abstract

      Loading...

    • +

      FP10.02 - Investigating the Immunophenotype of Small Cell Lung Cancer to Improve Immunotherapeutic Targeting

      00:00 - 00:00  |  Presenting Author(s): Kate Sutherland

      • Abstract

      Loading...

    • +

      FP10.03 - Multi-Region Exome Sequencing Reveals the Intratumoral Heterogeneity of Surgically Resected Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Huaqiang Zhou

      • Abstract

      Loading...

    • +

      FP10.04 - RESILIENT Part 1: Safety and Efficacy of Second-Line Liposomal Irinotecan in Patients with Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Luis G. Paz-Ares

      • Abstract

      Loading...

    • +

      FP10.05 - A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Kewei Ma

      • Abstract

      Loading...

  • +

    FP12 - Tumor Biology and Systems Biology - Basic and Translational Science

    • Type: Posters (Featured)
    • Track: Tumor Biology and Systems Biology - Basic and Translational Science
    • +

      FP12.01 - Circulating Tumor DNA to the Identification of EGFR Positive NSCLC Long-Term Survivors

      00:00 - 00:00  |  Presenting Author(s): Fernando Franco

      • Abstract

      Loading...

    • +

      FP12.03 - SRC-Homology 2 Domain-Containing Phosphatase 2 (SHP2) in Resected Lung Adenocarcinoma (LUAD)

      00:00 - 00:00  |  Presenting Author(s): Masaoki Ito

      • Abstract

      Loading...

    • +

      FP12.04 - Intelligent Label-Free Image-Based Profiling for Lung Cancer Cell Detection and Classification

      00:00 - 00:00  |  Presenting Author(s): Michelle Chi Kiu Lo

      • Abstract

      Loading...

    • +

      FP12.05 - Molecular Landscape of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Chinese Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Xiaomin Niu

      • Abstract

      Loading...

    • +

      FP12.06 - GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab

      00:00 - 00:00  |  Presenting Author(s): Edoardo Lenci

      • Abstract

      Loading...

    • +

      FP12.07 - Prognostic Value of HLA-I Homozygosity in Non-Small Cell Lung Cancer Patients Treated with Single Agent Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Afaf Abed

      • Abstract

      Loading...

    • +

      FP12.08 - The Survival Impact of Circulating T Regulatory Cells Subsets in Patients with Untreated Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Dahiana Amarillo

      • Abstract

      Loading...

    • +

      FP12.09 - Molecular Insight into NADIM Clinical Trial: Potential Immune Biomarkers of Pathological Response for NSCLC Patients.

      00:00 - 00:00  |  Presenting Author(s): Raquel Laza Briviesca

      • Abstract

      Loading...

    • +

      FP12.10 - IGF-1R Inhibition in Small Cell Lung Cancer: Role of Brigatinib

      00:00 - 00:00  |  Presenting Author(s): Apar Kishor Ganti

      • Abstract

      Loading...

    • +

      FP12.11 - Single-Cell RNA Sequencing Analyses Distinguishes Transcriptional Activity of c-Myc and L-Myc in Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Ayushi S Patel

      • Abstract

      Loading...

    • +

      FP12.12 - Lung Cancer in Women Never-Smokers: A Genomics Perspective of the Women’s Health Initiative (WHI) Cohort

      00:00 - 00:00  |  Presenting Author(s): Sitapriya Moorthi

      • Abstract

      Loading...

    • +

      FP12.13 - Therapeutic Index Predicts Clinical Outcome of both Treated and Treatment-Naïve NSCLC Patients Receiving Targeted- and Immune-Therapy

      00:00 - 00:00  |  Presenting Author(s): Xiaomin Niu

      • Abstract

      Loading...